Accession Number: | 0000899243-19-028658 |
Date: | 2019-12-05 |
Issuer: | MYRIAD GENETICS INC (MYGN) |
Original Submission Date: |
REITAN COLLEEN F
320 WAKARA WAY
SALT LAKE CITY, UT 84108
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-12-05 | A | 11,687 | a | $0.00 | 11,687 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | consists of restricted stock units granted pursuant to the company's 2017 employee, director and consultant equity incentive plan. each restricted stock unit represents a contingent right to receive one share of the company's common stock and vests on the anniversary of the date of grant. |